Equities
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)6,270.00
  • Today's Change-113.00 / -1.77%
  • Shares traded2.47m
  • 1 Year change+26.92%
  • Beta0.8717
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments738,982503,107471,970
Total Receivables, Net320,348514,283356,009
Total Inventory273,480292,206208,838
Prepaid expenses21,82718,77017,301
Other current assets, total11,7898,1719,543
Total current assets1,366,4261,336,5371,063,661
Property, plant & equipment, net420,701386,651352,107
Goodwill, net------
Intangibles, net19,86025,14121,974
Long term investments12,50511,47411,776
Note receivable - long term------
Other long term assets4,9475,4757,575
Total assets1,932,5471,869,7581,538,694
LIABILITIES
Accounts payable54,233144,05497,203
Accrued expenses94,64865,67465,074
Notes payable/short-term debt000
Current portion long-term debt/capital leases6,9756,4346,550
Other current liabilities, total132,361207,568158,595
Total current liabilities288,217423,730327,422
Total long term debt6,4807,6759,490
Total debt13,45514,10916,040
Deferred income tax5,7877,0867,614
Minority interest------
Other liabilities, total6,4836,8806,151
Total liabilities306,967445,371350,677
SHAREHOLDERS EQUITY
Common stock73,20273,20273,202
Additional paid-in capital69,35568,80668,223
Retained earnings (accumulated deficit)1,488,7381,293,3521,054,050
Treasury stock - common------
Unrealized gain (loss)162(205)91
Other equity, total(5877)(10768)(7549)
Total equity1,625,5801,424,3871,188,017
Total liabilities & shareholders' equity1,932,5471,869,7581,538,694
Total common shares outstanding1,6451,6451,644
Treasury shares - common primary issue343435
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.